Global Drotaverine Hydrochloride Injection 麻豆原创 Research Report 2025

Publication ID:

PB502253305

Publication Date:

February 28, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Drotaverine Hydrochloride Injection was valued at US$ 1037 million in the year 2024 and is projected to reach a revised size of US$ 1313 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Drotaverine Hydrochloride Injection is a kind of medicine mainly used to relieve smooth muscle spasm. Drotaverine Hydrochloride Injection contains drotaverine hydrochloride as the active ingredient. It is usually presented in the form of a sterile aqueous solution in injection vials, and is administered by intravenous injection, intramuscular injection or other injection methods.
North American market for Drotaverine Hydrochloride Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Drotaverine Hydrochloride Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Drotaverine Hydrochloride Injection include Jiangsu Lianhuan Pharmaceutical, Shanxi Nuocheng Pharmaceutical, Sanofi, Gedeon Richter, Teva Pharmaceutical, Tosun, American Remedies Healthcare, Criticine Care, Montage Laboratories, SKG Internationals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drotaverine Hydrochloride Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drotaverine Hydrochloride Injection.
The Drotaverine Hydrochloride Injection market size, estimations, and forecasts are provided in terms of sales volume (L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drotaverine Hydrochloride Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drotaverine Hydrochloride Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Jiangsu Lianhuan Pharmaceutical
Shanxi Nuocheng Pharmaceutical
Sanofi
Gedeon Richter
Teva Pharmaceutical
Tosun
American Remedies Healthcare
Criticine Care
Montage Laboratories
SKG Internationals
Moruf Life Sciences
Adorshea
PCD Pharma
Segment by Type
20mg/ml
10mg/ml
Segment by Application
Gastroenterology
Urology
Gynecology
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drotaverine Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drotaverine Hydrochloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Drotaverine Hydrochloride Injection 麻豆原创 Overview
1.1 Product Definition
1.2 Drotaverine Hydrochloride Injection by Type
1.2.1 Global Drotaverine Hydrochloride Injection 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 20mg/ml
1.2.3 10mg/ml
1.3 Drotaverine Hydrochloride Injection by Application
1.3.1 Global Drotaverine Hydrochloride Injection 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Gastroenterology
1.3.3 Urology
1.3.4 Gynecology
1.4 Global Drotaverine Hydrochloride Injection 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Drotaverine Hydrochloride Injection Revenue 2020-2031
1.4.2 Global Drotaverine Hydrochloride Injection Sales 2020-2031
1.4.3 Global Drotaverine Hydrochloride Injection 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Drotaverine Hydrochloride Injection 麻豆原创 Competition by Manufacturers
2.1 Global Drotaverine Hydrochloride Injection Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Drotaverine Hydrochloride Injection Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Drotaverine Hydrochloride Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Drotaverine Hydrochloride Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drotaverine Hydrochloride Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drotaverine Hydrochloride Injection, Product Type & Application
2.7 Global Key Manufacturers of Drotaverine Hydrochloride Injection, Date of Enter into This Industry
2.8 Global Drotaverine Hydrochloride Injection 麻豆原创 Competitive Situation and Trends
2.8.1 Global Drotaverine Hydrochloride Injection 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Drotaverine Hydrochloride Injection Players 麻豆原创 Share by Revenue
2.8.3 Global Drotaverine Hydrochloride Injection Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drotaverine Hydrochloride Injection 麻豆原创 Scenario by Region
3.1 Global Drotaverine Hydrochloride Injection 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Drotaverine Hydrochloride Injection Sales by Region: 2020-2031
3.2.1 Global Drotaverine Hydrochloride Injection Sales by Region: 2020-2025
3.2.2 Global Drotaverine Hydrochloride Injection Sales by Region: 2026-2031
3.3 Global Drotaverine Hydrochloride Injection Revenue by Region: 2020-2031
3.3.1 Global Drotaverine Hydrochloride Injection Revenue by Region: 2020-2025
3.3.2 Global Drotaverine Hydrochloride Injection Revenue by Region: 2026-2031
3.4 North America Drotaverine Hydrochloride Injection 麻豆原创 Facts & Figures by Country
3.4.1 North America Drotaverine Hydrochloride Injection 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Drotaverine Hydrochloride Injection Sales by Country (2020-2031)
3.4.3 North America Drotaverine Hydrochloride Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drotaverine Hydrochloride Injection 麻豆原创 Facts & Figures by Country
3.5.1 Europe Drotaverine Hydrochloride Injection 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Drotaverine Hydrochloride Injection Sales by Country (2020-2031)
3.5.3 Europe Drotaverine Hydrochloride Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drotaverine Hydrochloride Injection 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Drotaverine Hydrochloride Injection 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Drotaverine Hydrochloride Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Drotaverine Hydrochloride Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Drotaverine Hydrochloride Injection 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Drotaverine Hydrochloride Injection 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Drotaverine Hydrochloride Injection Sales by Country (2020-2031)
3.7.3 Latin America Drotaverine Hydrochloride Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Drotaverine Hydrochloride Injection 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Drotaverine Hydrochloride Injection 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Drotaverine Hydrochloride Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Drotaverine Hydrochloride Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drotaverine Hydrochloride Injection Sales by Type (2020-2031)
4.1.1 Global Drotaverine Hydrochloride Injection Sales by Type (2020-2025)
4.1.2 Global Drotaverine Hydrochloride Injection Sales by Type (2026-2031)
4.1.3 Global Drotaverine Hydrochloride Injection Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Drotaverine Hydrochloride Injection Revenue by Type (2020-2031)
4.2.1 Global Drotaverine Hydrochloride Injection Revenue by Type (2020-2025)
4.2.2 Global Drotaverine Hydrochloride Injection Revenue by Type (2026-2031)
4.2.3 Global Drotaverine Hydrochloride Injection Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Drotaverine Hydrochloride Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Drotaverine Hydrochloride Injection Sales by Application (2020-2031)
5.1.1 Global Drotaverine Hydrochloride Injection Sales by Application (2020-2025)
5.1.2 Global Drotaverine Hydrochloride Injection Sales by Application (2026-2031)
5.1.3 Global Drotaverine Hydrochloride Injection Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Drotaverine Hydrochloride Injection Revenue by Application (2020-2031)
5.2.1 Global Drotaverine Hydrochloride Injection Revenue by Application (2020-2025)
5.2.2 Global Drotaverine Hydrochloride Injection Revenue by Application (2026-2031)
5.2.3 Global Drotaverine Hydrochloride Injection Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Drotaverine Hydrochloride Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Jiangsu Lianhuan Pharmaceutical
6.1.1 Jiangsu Lianhuan Pharmaceutical Company Information
6.1.2 Jiangsu Lianhuan Pharmaceutical Description and Business Overview
6.1.3 Jiangsu Lianhuan Pharmaceutical Drotaverine Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Jiangsu Lianhuan Pharmaceutical Drotaverine Hydrochloride Injection Product Portfolio
6.1.5 Jiangsu Lianhuan Pharmaceutical Recent Developments/Updates
6.2 Shanxi Nuocheng Pharmaceutical
6.2.1 Shanxi Nuocheng Pharmaceutical Company Information
6.2.2 Shanxi Nuocheng Pharmaceutical Description and Business Overview
6.2.3 Shanxi Nuocheng Pharmaceutical Drotaverine Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Shanxi Nuocheng Pharmaceutical Drotaverine Hydrochloride Injection Product Portfolio
6.2.5 Shanxi Nuocheng Pharmaceutical Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Drotaverine Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Drotaverine Hydrochloride Injection Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Gedeon Richter
6.4.1 Gedeon Richter Company Information
6.4.2 Gedeon Richter Description and Business Overview
6.4.3 Gedeon Richter Drotaverine Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Gedeon Richter Drotaverine Hydrochloride Injection Product Portfolio
6.4.5 Gedeon Richter Recent Developments/Updates
6.5 Teva Pharmaceutical
6.5.1 Teva Pharmaceutical Company Information
6.5.2 Teva Pharmaceutical Description and Business Overview
6.5.3 Teva Pharmaceutical Drotaverine Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Pharmaceutical Drotaverine Hydrochloride Injection Product Portfolio
6.5.5 Teva Pharmaceutical Recent Developments/Updates
6.6 Tosun
6.6.1 Tosun Company Information
6.6.2 Tosun Description and Business Overview
6.6.3 Tosun Drotaverine Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Tosun Drotaverine Hydrochloride Injection Product Portfolio
6.6.5 Tosun Recent Developments/Updates
6.7 American Remedies Healthcare
6.7.1 American Remedies Healthcare Company Information
6.7.2 American Remedies Healthcare Description and Business Overview
6.7.3 American Remedies Healthcare Drotaverine Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 American Remedies Healthcare Drotaverine Hydrochloride Injection Product Portfolio
6.7.5 American Remedies Healthcare Recent Developments/Updates
6.8 Criticine Care
6.8.1 Criticine Care Company Information
6.8.2 Criticine Care Description and Business Overview
6.8.3 Criticine Care Drotaverine Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Criticine Care Drotaverine Hydrochloride Injection Product Portfolio
6.8.5 Criticine Care Recent Developments/Updates
6.9 Montage Laboratories
6.9.1 Montage Laboratories Company Information
6.9.2 Montage Laboratories Description and Business Overview
6.9.3 Montage Laboratories Drotaverine Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Montage Laboratories Drotaverine Hydrochloride Injection Product Portfolio
6.9.5 Montage Laboratories Recent Developments/Updates
6.10 SKG Internationals
6.10.1 SKG Internationals Company Information
6.10.2 SKG Internationals Description and Business Overview
6.10.3 SKG Internationals Drotaverine Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 SKG Internationals Drotaverine Hydrochloride Injection Product Portfolio
6.10.5 SKG Internationals Recent Developments/Updates
6.11 Moruf Life Sciences
6.11.1 Moruf Life Sciences Company Information
6.11.2 Moruf Life Sciences Description and Business Overview
6.11.3 Moruf Life Sciences Drotaverine Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Moruf Life Sciences Drotaverine Hydrochloride Injection Product Portfolio
6.11.5 Moruf Life Sciences Recent Developments/Updates
6.12 Adorshea
6.12.1 Adorshea Company Information
6.12.2 Adorshea Description and Business Overview
6.12.3 Adorshea Drotaverine Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Adorshea Drotaverine Hydrochloride Injection Product Portfolio
6.12.5 Adorshea Recent Developments/Updates
6.13 PCD Pharma
6.13.1 PCD Pharma Company Information
6.13.2 PCD Pharma Description and Business Overview
6.13.3 PCD Pharma Drotaverine Hydrochloride Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 PCD Pharma Drotaverine Hydrochloride Injection Product Portfolio
6.13.5 PCD Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drotaverine Hydrochloride Injection Industry Chain Analysis
7.2 Drotaverine Hydrochloride Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drotaverine Hydrochloride Injection Production Mode & Process Analysis
7.4 Drotaverine Hydrochloride Injection Sales and 麻豆原创ing
7.4.1 Drotaverine Hydrochloride Injection Sales Channels
7.4.2 Drotaverine Hydrochloride Injection Distributors
7.5 Drotaverine Hydrochloride Injection Customer Analysis
8 Drotaverine Hydrochloride Injection 麻豆原创 Dynamics
8.1 Drotaverine Hydrochloride Injection Industry Trends
8.2 Drotaverine Hydrochloride Injection 麻豆原创 Drivers
8.3 Drotaverine Hydrochloride Injection 麻豆原创 Challenges
8.4 Drotaverine Hydrochloride Injection 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Jiangsu Lianhuan Pharmaceutical
Shanxi Nuocheng Pharmaceutical
Sanofi
Gedeon Richter
Teva Pharmaceutical
Tosun
American Remedies Healthcare
Criticine Care
Montage Laboratories
SKG Internationals
Moruf Life Sciences
Adorshea
PCD Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.